From Queuosine Biosynthesis to Immune Catalysis: The QueC-Family Lineage
QueC (7-cyano-7-deazaguanine synthase) catalyzes two sequential ATP-dependent reactions that convert 7-carboxy-7-deazaguanine (CDG) into the nitrile product preQ0 during queuosine biosynthesis [3]. The discovery that Cap9, a QueC homolog encoded by type IV CBASS operons, instead conjugates CDG directly to the N-terminal glycine of a protein substrate—generating an N-terminal 7-amido-7-deazaguanine (NDG) modification—redefined the QueC family as potential immune effectors [6]. Cap9, its partner Cap10, and protein deazaguanylation were shown to be essential for host defense against phage infection, establishing that nucleobase biosynthetic machinery can be repurposed for antiviral immunity [6]. The qatABCD operon, identified in systematic defense gene surveys, encodes QatC as its QueC-domain-containing signature component alongside QatA (a KAP-family ATPase), QatB (a protein of unknown fold), and QatD (a predicted TatD-family nuclease) [2][3].
QatBC Crystal Structure Reveals a Conserved Substrate-Targeting Mechanism
The anchor paper solved the crystal structure of the QatBC complex at 2.09 Å resolution and an ATP-bound form at 2.66 Å, revealing that QatB and QatC form a compact assembly with a buried area of 4849.4 Ų [1]. QatC comprises a central QueC-like domain flanked by N- and C-terminal extensions; the QueC-like domain (residues 148–370) is highly structurally similar to Bacillus subtilis QueC and Rhizobiales Cap9, with conserved active-site residues S156/S161 and a pyrophosphate-binding SXGXDS motif [1]. The most notable feature is that the QatB N-terminal loop inserts into the putative active site of QatC, suggesting QatB acts as a substrate of QatC—analogous to how CdnD inserts its N-terminal loop into the Cap9 QueC-like domain, despite no structural homology between QatB and CdnD [1]. A zinc atom coordinated by a conserved CxxCxxC motif (C352, C355, C358) and C332 is also present; mutation of these four cysteines severely decreased anti-phage activity, suggesting a structural stabilizing role [1].
Functional Validation and the Unresolved Catalytic Reaction
Structure-guided mutational analyses confirmed that the QatC catalytic site, zinc-coordinating residues, and the QatB N-terminal loop are essential for anti-phage defense in vivo [1]. The ATP-bound structure showed that QatC F235 undergoes a conformational change to form π-π stacking with the adenine base, and the SXGXDS motif coordinates the β- and γ-phosphates of ATP; the α-phosphate is stabilized by a hydrogen bond from the N-terminal G2 of QatB [1]. However, despite extensive trials, the authors could not reconstitute QatC activity in vitro using CDG, ATP, and QatB, and no electron density for CDG was observed in the crystal [1]. This suggests QatC either requires a phage trigger for activation or utilizes a substrate distinct from CDG [1]. Notably, QatC residues T276 and T278 replace the Cap9/BsQueC residues Y115/D117 that stabilize the NDG modification, though these threonines are conserved among QatC homologs [1].
QatD Flexibility and Species-Specific Component Requirements
Despite crystallizing the QatBCD complex, only electron density for QatBC was observed, indicating that QatD is highly flexible in the complex [1]. AlphaFold3 predictions placed QatC and the QatB main body in positions matching the crystal structure, but QatD position varied greatly across top predictions, consistent with high flexibility [1]. A QatB Δ2–46 truncation lost QatD binding but retained QatC binding, and interface mutations outside the N-terminal loop had only minor effects on QatB-QatD binding, suggesting QatB-QatD interaction relies almost exclusively on insertion of the QatB N-terminal flexible loop into QatD [1]. Separately, QatD was characterized as a metal-dependent dual nuclease with Mg²⁺-dependent 3′-5′ exonuclease activity and Ca²⁺-dependent AP endonuclease activity, and its E95A/H133A mutation reduced both nuclease activity and phage defense [1][2]. A critical discrepancy exists: the anchor paper states that all four components are required for anti-phage activity in the E. coli NCTC9009 system [1], while a concurrent study found that a truncated qatABCD operon lacking qatA and qatD retained full defense against phage λvir in the P. aeruginosa system, with QatBC alone sufficient for defense against some phages [3]. The anchor paper acknowledges this, noting that for systems from different species distinct factors are needed for anti-phage activity [1].
Open Questions and Emerging Boundaries
The exact reaction catalyzed by QatC remains unknown; the structural evidence supports QatB as a substrate, but in vitro reconstitution failed, leaving open whether a phage trigger, a different substrate, or additional factors are required [1]. The complete mechanism of qatABCD-mediated defense remains unsolved, and the role of QatD in the system needs further study [1]. Additionally, phage-encoded kinases have been shown to phosphorylate QatABCD components as an immune evasion strategy: the Salmonella phage JSS1 protein JSS1_004 phosphorylates multiple bacterial immune systems including QatABCD [4], and the T7 kinase T7K was recently demonstrated to bind DNA and inactivate DNA-targeting defense systems including QatABCD by phosphorylation at critical residues [5]. These findings suggest that the QatABCD system operates within a broader arms race where post-translational modification by phage kinases can disable defense, adding another layer of complexity to understanding its in vivo function.
About These Sources
This research page is built on 6 peer-reviewed studies — published from 2024 to 2026, 6 from 2024 or later — selected as the most relevant from 7 studies that passed quality screening, drawn from 38 papers retrieved from a database of over 500 million.
Sources used in this answer
Structural and functional insights into QueC-family protein in QatABCD anti-phage system
The anchor paper solves crystal structures of the QatBC complex in apo and ATP-bound forms, demonstrates that the QatB N-terminal loop inserts into the QatC catalytic site, and shows through mutagenesis that QatC catalytic residues, zinc-coordinating cysteines, and the QatB N-terminal loop are essential for anti-phage defense in vivo, while QatD remains structurally unresolved and the QatC reaction could not be reconstituted in vitro.
Structural and enzymatic insights into QatD, a dual-function TatD-like nuclease in the QatABCD anti-phage defense system
This foundational paper characterizes QatD as a metal-dependent dual nuclease with Mg²⁺-dependent 3′-5′ exonuclease and Ca²⁺-dependent AP endonuclease activities, proposes a two-tiered self/non-self discrimination mechanism involving structural gating and NTP-dependent inhibition, and shows that QatD E95A/H133A mutation reduces both nuclease activity and phage defense.
Structural basis of QueC-family protein function in qatABCD anti-phage defense.
This precursor study on the Pseudomonas aeruginosa qatABCD system demonstrates that QatBC alone is sufficient for defense against phage λvir, that QatB G2D mutation and deletion of residues 16–22 abolish defense, and that QatA and QatD affect defensive range rather than being absolutely required in this species.
A widespread phage-encoded kinase enables evasion of multiple host antiphage defence systems
This competing evidence paper shows that the Salmonella phage JSS1 protein JSS1_004 is an N-terminal Ser/Thr/Tyr kinase that phosphorylates multiple host immune systems including QatABCD, impairing its antiphage activity.
Pervasive phosphorylation by phage T7 kinase disarms bacterial defences
This limitation evidence paper reports that the T7 kinase T7K is a hyperpromiscuous dual-specificity kinase capable of phosphorylating host proteins without sequence motif preference, and that it can bind DNA and inactivate DNA-targeting defense systems including QatABCD by phosphorylation at critical residues.
Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity.
This precursor paper defines the NDG (N-terminal 7-amido-7-deazaguanine) protein modification in type IV CBASS, showing that Cap9 conjugates CDG to the N-terminal glycine of CdnD and that Cap9, Cap10, and protein deazaguanylation are essential for anti-phage defense.